Altimmune
ALT
62 hedge funds and large institutions have $75.1M invested in Altimmune in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 0 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
43% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 14
32% more funds holding
Funds holding: 47 → 62 (+15)
22% more capital invested
Capital invested by funds: $61.7M → $75.1M (+$13.4M)
81% less call options, than puts
Call options by funds: $59K | Put options by funds: $317K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NRCM
Northern Right Capital Management
Darien,
Connecticut
|
+$1.34M |
| 2 |
Renaissance Technologies
New York
|
+$955K |
| 3 |
EA
Emerald Acquisition
Seattle,
Washington
|
+$636K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$571K |
| 5 |
State Street
Boston,
Massachusetts
|
+$469K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$2.56M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$375K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$131K |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$115K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$97.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Principal Financial Group
Des Moines,
Iowa
| $30K | – | – | – |
|
|
AP
52
Appleton Partners
Boston,
Massachusetts
| $30K | +$27.5K | +35 | New |
|
53
Creative Planning
Overland Park,
Kansas
| $26K | – | – | – |
|
|
LTFS
54
Ladenburg Thalmann Financial Services
Miami,
Florida
| $26K | – | – | – |
|
55
Bank of America
Charlotte,
North Carolina
| $25K | +$5.49K | +7 | +32% |
|
|
LYV
56
Live Your Vision
West Conshohocken,
Pennsylvania
| $22K | +$20.4K | +26 | New |
|
57
UBS Group
Zurich,
Switzerland
| $18K | +$16.5K | +21 | New |
|
58
Citigroup
New York
| $15K | -$3.14K | -4 | -19% |
|
59
BNP Paribas Financial Markets
Paris,
France
| $13.5K | +$5.49K | +7 | +88% |
|
60
BlackRock
New York
| $10K | +$3.14K | +4 | +57% |
|
61
Barclays
London,
United Kingdom
| $1K | +$784 | +1 | New |
|
|
TCIM
62
TIAA CREF Investment Management
New York
| $584 | – | – | – |
|
ALT Hedge Fund Activity: Q3 2016 in Review
62 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q3 2016, worth a combined $75.1M — up 22% from $61.7M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new ALT positions and 0 closed out — a net gain of 15 holders — while 20 added to existing stakes and 14 trimmed.
The largest buyer was Northern Right Capital Management, adding an estimated $1.34M. The largest seller was Hudson Bay Capital Management, cutting an estimated $2.56M.
- 62 institutional investors held Altimmune (ALT) as of Q3 2016, up from 47 in Q2 2016.
- Funds reported $75.1M of Altimmune stock for Q3 2016, up 22% quarter-over-quarter.
- 15 funds opened new Altimmune positions in Q3 2016 and 0 closed out, a net change of +15 holders.
- The largest Altimmune buyer in Q3 2016 was Northern Right Capital Management, an estimated $1.34M added.
- The largest Altimmune seller in Q3 2016 was Hudson Bay Capital Management, an estimated $2.56M sold.
Based on aggregated 13F filings for Q3 2016.